Skip to main content
Veterinary Medicines

Zipyran XL Tablets for Dogs

Authorised
  • Praziquantel
  • Febantel
  • Pyrantel embonate

Product identification

Medicine name:
ZIPYRAN XL 175 MG / 175 MG / 525 MG TABLETS FOR DOGS
Zipyran XL tabletten voor honden
Zipyran XL Tablets for Dogs
Active substance:
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    175.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    525.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    504.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Cardboard box containing 1 blister of 2 tablets
  • Cardboard box containing 30 blisters of 2 tablets
  • Cardboard box containing 24 blisters of 2 tablets
  • Cardboard box containing 16 blisters of 2 tablets
  • Cardboard box containing 12 blisters of 2 tablets
  • Cardboard box containing 5 blisters of 2 tablets
  • Cardboard box containing 2 blisters of 2 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
  • Beaphar B.V.
  • Beaphar B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 113470
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0224/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Germany
  • Greece
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/04/2022